SEA PHARMACEUTICALS

sea-pharmaceuticals-logo

Sea Pharmaceuticals is a neurological therapeutics R&D company creating and delivering innovative treatments for ALS and other disorders. Sea Pharmaceuticals was established in 2013 and is based in Cambridge, Massachusetts, United States.

#SimilarOrganizations #People #More

SEA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2013-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Total Employee:
1+

Status:
Active

Contact:
(617)794-9578

Total Funding:
1.29 M USD


Similar Organizations

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

shaker-sadasivam_image

Shaker Sadasivam Member Board Of Directors @ Sea Pharmaceuticals
Board_member
2016-11-01

shaker-sadasivam_image

Shaker Sadasivam Member Board Of Directors @ Sea Pharmaceuticals
Board_member
2016-11-01

Current Employees Featured

james-pearson_image

James Pearson
James Pearson President, CEO, Chief Science Officer (CSO), Founder, and Director @ Sea Pharmaceuticals
President, CEO, Chief Science Officer (CSO), Founder, and Director

Founder


james-pearson_image

James Pearson

More informations about "Sea Pharmaceuticals"

Sea Pharmaceuticals - Crunchbase Company Profile & Funding

Sea Pharmaceuticals is a neurotherapeutics company specializing in the development of new oral molecules for the treatment of tinnitus and epilepsy. The company invents, discovers, and โ€ฆSee details»

About | Sea Pharmaceuticals

Product Concept: Sea Pharmaceutical's proprietary synthetic small molecule treatments for Tinnitus, Epilepsy, and Sporadic ALS Sea Pharmaceuticals, LLC founded 2013 private, US investors neurotherapeutics R-&-D company in โ€ฆSee details»

Sea Pharmaceuticals LLC - Org Chart, Teams, Culture

View Sea Pharmaceuticals LLC's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Sea Pharmaceuticals LLC - LinkedIn

Sea Pharmaceuticals LLC Pharmaceutical Manufacturing Cambridge, Massachusetts 827 followers A neurotherapeutics R&D Co. advancing innovative new oral molecules potential to treat Tinnitus ...See details»

Sea Pharmaceuticals 2025 Company Profile: Valuation, Funding ...

Information on valuation, funding, cap tables, investors, and executives for Sea Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

About | Sea Pharmaceuticals

We are delighted to be a strategic partner with Sea Pharma." About Sea Pharmaceuticals LLC (Sea) is a private pre-clinical stage therapeutics research-and-development (R&D) company founded by J.P. Pearson and E. J. โ€ฆSee details»

Sea Pharmaceuticals LLC

Explore Sea Pharmaceuticals LLC with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases, โ€ฆSee details»

Sea Pharmaceuticals - Contacts, Employees, Board Members, โ€ฆ

Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.See details»

Sea Pharmaceuticals LLC Overview | SignalHire Company Profile

Sea Pharmaceuticals is a neurotherapeutics company specializing in the development of new oral molecules for the treatment of tinnitus and epilepsy. The company invents, discovers, and โ€ฆSee details»

Sea Pharmaceuticals - 2025 Company Profile - Tracxn

4 days ago Sea Pharmaceuticals - Developer of therapeutics for the treatment of CNS disorders. Raised a total funding of $1.51M over 2 rounds. Founded by Eduardo J Martinez in the year โ€ฆSee details»

Sea Pharmaceuticals - Crustdata Company Profile, Funding and โ€ฆ

Sea Pharmaceuticals is a neurotherapeutics company specializing in the development of new oral molecules for the treatment of tinnitus and epilepsy. The company invents, discovers, and โ€ฆSee details»

Team | Sea Pharmaceuticals

James P. Pearson, PhD - President, CEO, CSO, Investor, FTE, Founder Eduardo J. Martinez, PhD - VP Chemistry, Co-FounderSee details»

James P Pearson - The Org

James P founded Sea Pharmaceuticals in 2013 and currently holds the positions of President, CEO, Chief Science Officer, Founder, and Director. Prior to this, they worked as a Contract โ€ฆSee details»

Sea Pharmaceuticals - Overview, News & Similar companies

View Sea Pharmaceuticals (www.seapharmaceuticals.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Sea Pharmaceuticals - Funding, Financials, Valuation & Investors

Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.See details»

Sea Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Sea Pharmaceuticals primarily collaborates with key opinion leaders, contract organizations, and academic labs in neuroscience and related fields. It was founded in 2013 and is based in โ€ฆSee details»

Sea Pharmaceuticals Advancing Oral Neurotherapeutics as โ€ฆ

Nov 14, 2024 CAMBRIDGE, MA / ACCESSWIRE / November 14, 2024 / Sea Pharmaceuticals, LLC (Sea) today announced the advancement of two orally-administered neurotherapeutic โ€ฆSee details»

Roadmaps to Nature Positive: Foundations for the pharmaceutical โ€ฆ

6 hours ago The Roadmaps provide in-depth analysis and guidance relevant for all businesses, as well as specific guidance for the pharmaceutical sector and four high-impact systems: land โ€ฆSee details»

Pharmaceutical Tariffs: Potential Impacts And The Need For ...

23 hours ago The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful vulnerability assessments should be conducted so that โ€ฆSee details»

About | Sea Pharmaceuticals

Date Title Nov 14, 2024 Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChemSee details»

linkstock.net © 2022. All rights reserved